Qiagen N.V. (QGEN)
NYSE: QGEN · IEX Real-Time Price · USD
41.65
+0.57 (1.39%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Qiagen Employees
Qiagen had 5,967 employees on December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$329,363
Profits / Employee
$57,198
Market Cap
9.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5,967 | -211 | -3.42% |
Dec 31, 2022 | 6,178 | 150 | 2.49% |
Dec 31, 2021 | 6,028 | 418 | 7.45% |
Dec 31, 2020 | 5,610 | 514 | 10.09% |
Dec 31, 2019 | 5,096 | 144 | 2.91% |
Dec 31, 2018 | 4,952 | 264 | 5.63% |
Dec 31, 2017 | 4,688 | 4 | 0.09% |
Dec 31, 2016 | 4,684 | 125 | 2.74% |
Dec 31, 2015 | 4,559 | 220 | 5.07% |
Dec 31, 2014 | 4,339 | 324 | 8.07% |
Dec 31, 2013 | 4,015 | 16 | 0.40% |
Dec 31, 2012 | 3,999 | 61 | 1.55% |
Dec 31, 2011 | 3,938 | 351 | 9.79% |
Dec 31, 2010 | 3,587 | 92 | 2.63% |
Dec 31, 2009 | 3,495 | 454 | 14.93% |
Dec 31, 2008 | 3,041 | 379 | 14.24% |
Dec 31, 2007 | 2,662 | 708 | 36.23% |
Dec 31, 2006 | 1,954 | 365 | 22.97% |
Dec 31, 2005 | 1,589 | 267 | 20.20% |
Dec 31, 2004 | 1,322 | -231 | -14.87% |
Dec 31, 2003 | 1,553 | -98 | -5.94% |
Dec 31, 2002 | 1,651 | 94 | 6.04% |
Dec 31, 2001 | 1,557 | 242 | 18.40% |
Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Chemed | 15,087 |
Teleflex | 14,500 |
AptarGroup | 13,800 |
Stevanato Group | 5,634 |
Legend Biotech | 1,826 |
QGEN News
- 3 days ago - QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance - GlobeNewsWire
- 19 days ago - QIAGEN N.V. to release results for Q1 2024 and hold webcast - GlobeNewsWire
- 24 days ago - QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 - GlobeNewsWire
- 4 weeks ago - MyBio Are the New Exclusive Partner for QIAGEN in Ireland & Northern Ireland - Business Wire
- 4 weeks ago - QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system - GlobeNewsWire
- 5 weeks ago - QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements - GlobeNewsWire
- 6 weeks ago - QIAGEN announces Form 20-F annual report filing for 2023 results - GlobeNewsWire
- 2 months ago - QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery - GlobeNewsWire